OpenAI Enhances ChatGPT Health Intelligence for Personalised Care

Executive Summary

LONDON, 19 June 2026 — OpenAI has announced a significant advancement in healthcare AI with the enhancement of health intelligence features in ChatGPT. The update enables more personalised healthcare insights by allowing users to input a personal health profile — including conditions, medications, allergies, and health goals — so that ChatGPT can deliver contextually relevant, evidence-grounded responses. The feature is initially available to ChatGPT Plus and Pro subscribers in the United States, with broader rollout expected pending evaluation.

What Changed

OpenAI's latest update marks a meaningful step in the integration of AI within everyday healthcare. ChatGPT can now process user-defined health profiles and generate responses grounded in peer-reviewed literature and established clinical guidelines published by bodies including the National Institutes of Health and the World Health Organisation. The feature was developed in collaboration with healthcare professionals who reviewed response quality and clinical accuracy. Full details of the announcement are available on OpenAI's official news page.

Critically, OpenAI has structured the feature around a clear disclaimer framework: every health response explicitly states it is informational only and not a substitute for professional medical advice. The company states that health profile data is not used to train its models — a commitment that aligns with HIPAA data-handling standards.

Why This Matters for Patients and Clinicians

The implications are substantive. Patients managing chronic conditions now have access to an AI system that can factor in their specific medical context when answering questions — a step closer to the vision articulated by researchers in the New England Journal of Medicine and JAMA around AI-assisted patient education. For clinicians, the downstream effect may be better-prepared patients entering consultations, having already engaged with relevant clinical literature in plain language.

The FDA has previously noted that AI tools in healthcare carry both opportunity and risk, particularly around accuracy and over-reliance. OpenAI's decision to anchor responses in established guidelines and issue consistent disclaimers reflects awareness of this regulatory context. Analysis published by the Financial Times has highlighted the tension between personalisation and safety in consumer health AI — a tension this update directly addresses through its governance framework.

Privacy and Data Governance

OpenAI has emphasised that health data provided through the personal profile is handled under protocols aligned with HIPAA. Users retain full control: health profile data can be deleted at any time, and it is not used to improve or train the underlying model. This approach directly addresses the concerns raised by privacy advocates and regulators in the British Medical Journal and elsewhere regarding the secondary use of sensitive health data by AI platforms. The Reuters Technology desk has previously reported on regulatory scrutiny facing AI health tools, making OpenAI's explicit HIPAA alignment a notable signal to policymakers.

What Happens Next

The initial United States rollout will serve as a quality and safety evaluation phase. OpenAI has indicated it will use feedback from this phase — in conjunction with its healthcare professional advisory process — to refine responses before broader geographic expansion. The company's track record in life sciences AI, including work documented in its LifeSciBench drug discovery evaluations, suggests a methodical approach to health sector deployment. Bloomberg Technology has noted increased investment across the sector in clinically validated AI tools, a trend this update positions ChatGPT to compete within directly. The broader shift toward AI-augmented primary care, tracked by analysts at the Financial Times, is moving faster than most health system infrastructure can absorb — and OpenAI's move into personalised health guidance places it at the centre of that tension.